Japan· JP-2221002X1012
エフェドリン塩酸塩
A ephedrine product containing エフェドリン塩酸塩, registered in Japan, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Ephedrine is registered in 15 of 19 countries.
Countries holding a registration under ATC C01CA26 (ephedrine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 8 of them publish a price we can compare per daily dose
Ephedrine · ATC C01CA26
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- エフェドリン塩酸塩
- Manufacturer
- —
- Country
- Japan (JP)
- ATC code
- C01CA26
- ATC class
- Ephedrine
- Defined daily dose
- 50 mg, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
223 interactions on record for ephedrine.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ephedrine · interactions on record
223 records
- 31 severe
- 177 moderate
- 15 minor
Most severe, free to view
- SibutramineA08AA10severe
- MethylergometrineG02AB01severe
- ErgometrineG02AB03severe
- LinezolidJ01XX08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C01CA26
Ephedrine, as other registers publish it.
- United StatesAkovazExela Pharma Sciences, LLC
- United StatesAkovazExela Pharma Sciences, LLC
- United StatesBronkaidFoundation Consumer Healthcare LLC
- United KingdomCAM MixtureCambridge Healthcare Supplies Ltd
- United KingdomDo-Do ChestEze tabletsNovartis Consumer Health UK Ltd
- United KingdomDolvan tabletsNorma Chemicals Ltd
- NorwayEfedrinEvolan Pharma AB
- DenmarkEfedrin "Abboxia"Abboxia AB
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcb8d4e3-1f5a-4577-aeaf-89f7846939df GET /v1/drugs/bcb8d4e3-1f5a-4577-aeaf-89f7846939df?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１ｇ",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "2221002X1012",
"category": "内用薬",
"price_yen": null,
"generic_name": "エフェドリン塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2221",
"transitional_expiry": null
}See everything about ephedrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.